Melanoma is the main cause of skin cancer deaths, with special emphasis in those cases carrying BRAF mutations that trigger mitogen-activated protein kinases (MAPK) signaling and unrestrained cell proliferation absence mitogens. Current therapies targeting MAPK are hindered by drug resistance relapse rely on metabolic rewiring Akt activation. To identify new candidates against melanoma, we inve...